An impurity of Felypressin.Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found in various sites around the body. The major points include the CNS, Liver, Anterior Pituitary, Muscle (both vascular and non-vascular smooth muscle), and Platelets (CLAMP).
CAT No: 10-101-188
Felypressin Impurity A is a synthetic peptide derivative structurally related to felypressin, a vasopressin analog commonly utilized in biochemical and pharmaceutical research. As a well-defined peptide impurity, it serves as a critical analytical reference for quality control and characterization studies involving felypressin and its related compounds. The unique sequence and physicochemical properties of this molecule provide valuable insights into peptide stability, degradation pathways, and the overall integrity of peptide-based formulations. Its defined structure and relevance to peptide research make it an indispensable tool for laboratories focused on peptide synthesis, analytical method development, and impurity profiling.
Analytical Reference Standard: In pharmaceutical and biochemical laboratories, Felypressin Impurity A is widely employed as a reference standard for the identification and quantification of process-related impurities in peptide manufacturing. Utilizing this impurity as a benchmark enables analysts to validate chromatographic methods such as HPLC or LC-MS, ensuring accurate detection, resolution, and quantification of minor components within complex peptide mixtures. Its availability supports the rigorous quality assessment of peptide batches, facilitating compliance with stringent research and production protocols.
Peptide Impurity Profiling: The compound plays a vital role in impurity profiling studies, where understanding the presence and behavior of structurally related analogs is essential for peptide drug development and research. By incorporating Felypressin Impurity A into analytical workflows, scientists can map degradation products, elucidate synthetic by-products, and monitor the stability of primary peptide substances under various storage or processing conditions. This information is crucial for refining synthetic routes, optimizing purification strategies, and ensuring the reproducibility of peptide preparations.
Method Development and Validation: Felypressin Impurity A is integral to the development and validation of analytical methods aimed at detecting peptide impurities. Laboratories routinely use this impurity to establish system suitability, determine detection limits, and assess method robustness. Its inclusion in validation protocols strengthens the reliability of impurity assays, supporting the generation of reproducible and accurate data for research and industrial applications involving vasopressin analogs.
Peptide Synthesis Optimization: In the context of peptide synthesis, the presence and characterization of impurities such as Felypressin Impurity A provide valuable feedback on the efficiency and selectivity of synthetic methodologies. By analyzing the formation and profile of this impurity, researchers can identify potential side reactions, optimize reaction conditions, and improve the overall yield and purity of the target peptide. This approach enhances the scalability and cost-effectiveness of peptide production processes, particularly for research-use compounds.
Stability and Degradation Studies: The compound is frequently utilized in forced degradation and stability testing protocols to simulate and analyze the breakdown of peptide formulations over time. Introducing Felypressin Impurity A into stability studies enables the identification of degradation pathways and the assessment of formulation robustness under various environmental or processing stresses. The resulting data contribute to a deeper understanding of peptide shelf life, storage requirements, and the long-term behavior of peptide products in research and industrial settings.
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More